Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2025-08-10 Major Shareholding Noti…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Ceasing to be a substantial holder 3 pages 658.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and voting securities of a substantial holder, including dates and transaction details. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2025-08-10 English
OSX & Universiti Malaya initiate dental bone healing trial 4 pages 407.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 August 2025 about Osteopore Limited embarking on a clinical study with Universiti Malaya. It discusses the study's purpose, ethics approval, and comments from the CEO and lead researcher. There are no financial statements, regulatory filings, or detailed financial data. The content is a corporate announcement about a clinical study initiation, not a financial report, management change, or shareholder vote. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate update announcement. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2025-08-07 English
Change in substantial holding 3 pages 782.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in a company, including dates, share counts, and nature of changes. This form is a regulatory filing used to notify the market and regulators about changes in significant share ownership levels. It is not a financial report, earnings release, or management information, but a notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not just an announcement or certification.
2025-08-07 English
Change in substantial holding 3 pages 783.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in a company, including dates, share quantities, and nature of changes. This form is a regulatory filing used to notify the market and regulators about changes in significant share ownership levels. It is not a financial report, earnings release, or management information. It fits the definition of a Major Shareholding Notification (MRQ) as it reports changes in substantial share ownership crossing thresholds.
2025-08-05 English
OSX ortho product successful in Vietnam hospital tender bids 3 pages 390.4KB
Capital/Financing Update Classification · 85% confidence The document is an ASX announcement dated 4 August 2025 about Osteopore winning two public hospital tender bids in Vietnam for its orthopaedic products. It discusses market approvals, tender values, market growth projections, and next steps for logistics and supply arrangements. There are no financial statements, quarterly or annual results, or detailed financial data. The document is a corporate announcement about business development and contract wins, not a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information about the tender wins and business progress. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes, here interpreted broadly as business development and contract wins impacting company revenue streams and market entry.
2025-08-03 English
Activities Report June 2025 and Appendix 4C 15 pages 12.6MB
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly report from Osteopore Limited, including detailed financial data such as revenue figures, cash flow statements, and operational highlights for the quarter ended 30 June 2025. It includes an Appendix 4C Quarterly Cash Flow Report, which is a regulatory requirement for quarterly reporting on cash flows and financing activities. The document contains substantive financial data and analysis, not just an announcement or summary. The presence of detailed cash flow tables, operating activities, investing and financing activities, and commentary on quarterly performance confirms this is a comprehensive interim/quarterly financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-07-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.